Helicos BioSciences (FRA:HB4) 14-Day RSI : N/A (As of Jun. 22, 2024)

View and export this data going back to . Start your Free Trial

What is Helicos BioSciences 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-06-22), Helicos BioSciences's 14-Day RSI is N/A.

The industry rank for Helicos BioSciences's 14-Day RSI or its related term are showing as below:

FRA:HB4's 14-Day RSI is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 45.94
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Helicos BioSciences's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Helicos BioSciences's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helicos BioSciences's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Helicos BioSciences's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Helicos BioSciences's 14-Day RSI falls into.

Helicos BioSciences (FRA:HB4) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI

100

–

[ 100

( 1 + Average Gain

Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helicos BioSciences (FRA:HB4) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

Helicos BioSciences 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Helicos BioSciences's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.

Helicos BioSciences (FRA:HB4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Helicos BioSciences Corp (FRA:HB4) » Definitions » 14-Day RSI

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Helicos BioSciences Corp is incorporated in the state of Delaware and was incorporated on May 9, 2003. It is a life sciences company focused on genetic analysis technologies for the research, drug discovery and clinical diagnostics markets. The Company's products are based on its proprietary True Single Molecule Sequencing (tSMS) technology which enables rapid analysis of large quantities of genetic material by directly sequencing single molecules of DNA or single DNA copies of RNA. The Company's Helicos Genetic Analysis Platform is designed to obtain sequencing information by repetitively performing a cycle of biochemical reactions on individual DNA molecules and imaging the results after each cycle. The platform consists of an instrument called the HeliScope Single Molecule Sequencer, an image analysis computer tower called the HeliScope Analysis Engine, associated reagents, which are chemicals used in the sequencing process, and disposable supplies. The Company is subject, both directly and indirectly, to the adverse impact of existing and potential future government regulation of its operations and markets.

Helicos BioSciences (FRA:HB4) Headlines

No Headlines